Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Back

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected personsLaura Dickinson, Saye Khoo, David Back
The Journal of Antimicrobial Chemotherapy|March 26, 2010
New directly acting antivirals for hepatitis C: potential for interaction with antiretroviralsKay Seden, David Back, Saye Khoo
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of etravirineLaura Dickinson, Saye Khoo, David Back
Therapeutic Drug Monitoring|June 17, 2006
An update on therapeutic drug monitoring for antiretroviral drugsDavid Back, Sara Gibbons, Saye Khoo
Antiviral Research|August 12, 2009
Pharmacokinetics and drug-drug interactions of antiretrovirals: an updateLaura Dickinson, Saye Khoo, David Back
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageableKay Seden, David Back, Saye Khoo
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Pharmacokinetic drug interactions with nevirapineDavid Back, Sara Gibbons, Saye Khoo
AIDS (London, England)|November 7, 2015
Twenty years of boosting antiretroviral agents: where are we today?Marta Boffito, David Back, José M Gatell
The Journal of Antimicrobial Chemotherapy|March 7, 2016
Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medicationsCatia Marzolini, Sara Gibbons, Saye Khoo, et al.
Drugs|December 15, 2010
Grapefruit-drug interactionsKay Seden, Laura Dickinson, Saye Khoo, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Current Opinion in HIV and AIDS|April 18, 2009
Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected personsLaura Dickinson, Saye Khoo, David Back
The Journal of Antimicrobial Chemotherapy|March 26, 2010
New directly acting antivirals for hepatitis C: potential for interaction with antiretroviralsKay Seden, David Back, Saye Khoo
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of etravirineLaura Dickinson, Saye Khoo, David Back
Therapeutic Drug Monitoring|June 17, 2006
An update on therapeutic drug monitoring for antiretroviral drugsDavid Back, Sara Gibbons, Saye Khoo
Antiviral Research|August 12, 2009
Pharmacokinetics and drug-drug interactions of antiretrovirals: an updateLaura Dickinson, Saye Khoo, David Back
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageableKay Seden, David Back, Saye Khoo
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Pharmacokinetic drug interactions with nevirapineDavid Back, Sara Gibbons, Saye Khoo
AIDS (London, England)|November 7, 2015
Twenty years of boosting antiretroviral agents: where are we today?Marta Boffito, David Back, José M Gatell
The Journal of Antimicrobial Chemotherapy|March 7, 2016
Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medicationsCatia Marzolini, Sara Gibbons, Saye Khoo, et al.
Drugs|December 15, 2010
Grapefruit-drug interactionsKay Seden, Laura Dickinson, Saye Khoo, et al.
Pageof 15